GOLT1A: A Potential Drug Target and Biomarker (G127845)
GOLT1A: A Potential Drug Target and Biomarker
GOLT1A (YMR292W), a gene located on chromosome 16, has been identified as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative disorders, and psychiatric conditions. Its unique structure and expression pattern make it an attractive target for researchers to study and develop new treatments.
GOLT1A is a gene that encodes the protein GOLT1A, which is a key regulator of the transport of nucleotides into the nucleus. The GOLT1A protein plays a crucial role in maintaining the stability of chromatin and in regulating gene expression. It is expressed in most tissues and cells of the body and has been implicated in various biological processes, including cell growth, differentiation, and inflammation.
One of the key features of GOLT1A is its expression pattern. GOLT1A is highly expressed in the brain and has been found to be involved in the development and progression of various psychiatric conditions, such as depression, anxiety, and schizophrenia. Studies have shown that individuals with certain genetic variations in the GOLT1A gene are at increased risk for developing these conditions.
Another promising aspect of GOLT1A is its potential as a drug target. By targeting the GOLT1A protein, researchers can potentially develop new treatments for psychiatric conditions and other diseases. One approach to targeting GOLT1A is through the use of small molecules, such as drugs that can modulate the activity of the GOLT1A protein. These molecules have been shown to be effective in treating various psychiatric conditions, including depression and anxiety.
In addition to its potential as a drug target, GOLT1A is also a potential biomarker for various diseases. Its expression pattern makes it an attractive target for diagnostic tests that can detect changes in the levels of GOLT1A protein in certain tissues or fluids. For example, studies have shown that GOLT1A is highly expressed in the brains of individuals with Alzheimer's disease, and the levels of GOLT1A have been found to be reduced in the brains of individuals with Parkinson's disease.
GOLT1A's unique structure also makes it an attractive target for researchers who are interested in understanding the underlying mechanisms of its function. Studies have shown that GOLT1A plays a role in regulating the activity of other genes, including those involved in cell signaling and DNA replication. By studying the GOLT1A protein at the molecular level, researchers can gain new insights into its function and how it contributes to various biological processes.
In conclusion, GOLT1A is a gene that has the potential to be a drug target and biomarker for various diseases. Its unique structure and expression pattern make it an attractive target for researchers who are interested in studying its function and developing new treatments. Further research is needed to fully understand the role of GOLT1A in various biological processes and to determine its potential as a drug and biomarker.
Protein Name: Golgi Transport 1A
Functions: May be involved in fusion of ER-derived transport vesicles with the Golgi complex
The "GOLT1A Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about GOLT1A comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
GOLT1B | GON4L | GON7 | GOPC | GORAB | GORASP1 | GORASP2 | GOSR1 | GOSR2 | GOT1 | GOT1-DT | GOT1L1 | GOT2 | GOT2P1 | GP1BA | GP1BB | GP2 | GP5 | GP6 | GP9 | GPA33 | GPAA1 | GPALPP1 | GPAM | GPANK1 | GPAT2 | GPAT3 | GPAT4 | GPATCH1 | GPATCH11 | GPATCH2 | GPATCH2L | GPATCH3 | GPATCH4 | GPATCH8 | GPBAR1 | GPBP1 | GPBP1L1 | GPC1 | GPC1-AS1 | GPC2 | GPC3 | GPC4 | GPC5 | GPC5-AS1 | GPC5-AS2 | GPC6 | GPC6-AS1 | GPC6-AS2 | GPCPD1 | GPD1 | GPD1L | GPD2 | GPER1 | GPHA2 | GPHB5 | GPHN | GPI | GPI transamidase complex | GPI-GlcNAc transferase complex | GPIHBP1 | GPKOW | GPLD1 | GPM6A | GPM6B | GPN1 | GPN2 | GPN3 | GPNMB | GPR101 | GPR107 | GPR108 | GPR119 | GPR12 | GPR132 | GPR135 | GPR137 | GPR137B | GPR137C | GPR139 | GPR141 | GPR142 | GPR143 | GPR146 | GPR148 | GPR149 | GPR15 | GPR150 | GPR151 | GPR152 | GPR153 | GPR155 | GPR156 | GPR157 | GPR158 | GPR158-AS1 | GPR15LG | GPR160 | GPR161 | GPR162
